Tabernanthe

About

An independent resource on ibogaine policy, research, and public understanding.

Evidence-first by design

People engaging in a thoughtful conversation about Americans For Ibogaine

Why this resource exists

Clear context for a complex, evolving issue.

Tabernanthe is an independent resource on ibogaine research, regulation, safety, and policy in the United States. It supports clear, evidence-first understanding of a complex and evolving issue. The main resource on Americans For Ibogaine provides the wider context; this page explains the standards behind the work.

Our editorial approach

The commitments that guide Tabernanthe.

I.

Independence

Information is organized to support understanding, not to direct a personal decision or represent a provider’s interests.

II.

Evidence first

We distinguish established records from emerging findings and make room for uncertainty where the record does not support a simple answer.

III.

Plain language

Complex material is presented with care and clarity, so readers can identify what a source says and what it does not say.

What we cover

A structured path through public information.

Tabernanthe organizes material by the questions readers commonly encounter: policy context, research records, safety considerations, and the public language surrounding the subject. Our resource pathways clarify how these areas are arranged without presenting recommendations or treatment guidance.

Where readers encounter location-specific material, we preserve its context: perspectives on Mexico ibogaine treatment, Canadian treatment center information, and ibogaine clinic discussions in Mexico are external material, not endorsements by Tabernanthe.

“A useful resource makes its sources visible, its limits plain, and its distinctions durable.”

Tabernanthe editorial principle

How information is vetted

Source-led, careful about scope.

We begin with primary and official records when available, then use literature and public registries to establish context. For example, the ClinicalTrials.gov registry is a useful reference point for identifying registered study records, while the U.S. Food and Drug Administration provides official material relevant to regulatory questions.

We do not treat a description as proof, or a single source as a final answer. Materials about how ibogaine is described to work and reports concerning ibogaine clinical trials in Texas are approached as claims that require context, source checking, and clear limits.

  • Safety awareness. Risks and uncertainty are not minimized for the sake of a neat narrative.
  • Policy clarity. Official language and public discussion are kept distinct.
  • Source transparency. Readers should be able to recognize the kind of record behind a statement.
  • Plain limits. This resource does not offer medical, legal, or individualized advice.

Independent by design

Information, not instruction.

Tabernanthe is an independent editorial resource. It is not a clinic, medical provider, licensed treatment center, or legal authority, and it does not provide medical or legal advice. Our purpose is to make public information easier to approach with care, context, and appropriate caution.

Contact Tabernanthe